Associated Papers
SMARCAL1 is a candidate therapeutic target for ALT-positive tumors.
Taglialatela A et al.
Biorxiv : the Preprint Server for Biology, 2026
Strand annealing and motor driven activities of SMARCAL1 and ZRANB3 are stimulated by RAD51 and the paralog complex.
Halder S et al.
Nucleic Acids Research, 2022
Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
Kolinjivadi AM et al.
Molecular Cell, 2017
Select a paper to view details